Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Mabs|March 23, 2019
Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodiesYi-Chun Hsiao, Yonglei Shang, Danielle M DiCara, et al.Mabs|December 9, 2016
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cellsMichael Dillon, Yiyuan Yin, Jianhui Zhou, et al.Science Translational Medicine|October 19, 2018
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3Dionysos Slaga, Diego Ellerman, T Noelle Lombana, et al.Pharmaceutics|May 28, 2022
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell MalignanciesRajbharan Yadav, Siddharth Sukumaran, Tanja S Zabka, et al.Mabs|December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo propertiesAyse Meric Ovacik, Ji Li, Marie Lemper, et al.Molecular Cancer Therapeutics|February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian CancerAmy A Lo, Jennifer Johnston, Ji Li, et al.Cancer Research|September 18, 2014
Antitumor efficacy of a bispecific antibody that targets HER2 and activates T cellsTeemu T Junttila, Ji Li, Jennifer Johnston, et al.Blood|December 3, 2016
An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemiaSteven R Leong, Siddharth Sukumaran, Maria Hristopoulos, et al.Cancer Cell|March 7, 2017
Membrane-Proximal Epitope Facilitates Efficient T Cell Synapse Formation by Anti-FcRH5/CD3 and Is a Requirement for Myeloma Cell KillingJi Li, Nicola J Stagg, Jennifer Johnston, et al.Science Translational Medicine|May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignanciesLiping L Sun, Diego Ellerman, Mary Mathieu, et al.Pageof 3